Welcome to LookChem.com Sign In|Join Free

CAS

  • or

659724-77-3

Post Buying Request

659724-77-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

659724-77-3 Usage

Chemical Class

Benzimidazole

Explanation

The compound belongs to the benzimidazole class of chemicals, which are characterized by a benzene ring fused to an imidazole ring.

Explanation

The compound contains a hydroxyl group, which is a functional group consisting of an oxygen atom bonded to a hydrogen atom (-OH).

Explanation

The compound has a methyl group attached to the alpha carbon, which is an alkyl group consisting of one carbon atom bonded to three hydrogen atoms (-CH3).

Explanation

The alpha carbon is the chiral center in the compound, meaning it is a carbon atom bonded to four different groups, giving rise to stereoisomers.

Explanation

The (alphaR) designation indicates the stereochemistry of the compound, specifically the configuration of the substituents around the chiral center. This information is crucial for understanding the compound's biological activity and potential applications.

Explanation

Due to its unique structure and properties, 1H-Benzimidazole-2-methanol,alpha-methyl-,(alphaR)-(9CI) may have potential uses in pharmaceutical research and chemical synthesis. However, further research and experimentation are needed to fully understand its potential applications.

Explanation

Additional research and experimentation are required to explore the compound's properties, potential applications, and any possible side effects or limitations. This information is essential for determining its suitability for specific uses in the pharmaceutical or chemical industries.

Hydroxyl Group

Presence of -OH group

Methyl Group

Presence of -CH3 group

Alpha Carbon

Chiral center

Stereochemistry

(alphaR)-configuration

Potential Applications

Pharmaceutical research and chemical synthesis

Further Research

Necessary for understanding properties and applications

Check Digit Verification of cas no

The CAS Registry Mumber 659724-77-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,5,9,7,2 and 4 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 659724-77:
(8*6)+(7*5)+(6*9)+(5*7)+(4*2)+(3*4)+(2*7)+(1*7)=213
213 % 10 = 3
So 659724-77-3 is a valid CAS Registry Number.

659724-77-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name (1R)-1-(1H-benzo[d]imidazol-2-yl)ethanol

1.2 Other means of identification

Product number -
Other names (1R)-1-(1H-benzimidazol-2-yl)ethanol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:659724-77-3 SDS

659724-77-3Downstream Products

659724-77-3Relevant articles and documents

Achievement of Bulky Homochirality in Zeolitic Imidazolate-Related Frameworks

Wang, Fei,Tang, Yu-Huan,Zhang, Jian

supporting information, p. 11064 - 11066 (2015/12/17)

Before this work, adding chiral C centers into zeolitic imidazolate frameworks (ZIFs) has never been realized. Presented here are the first examples on achieving bulky homochirality in ZIF systems, and three homochiral zeolitic imidazolate-related frameworks with sodalite and dia topologies are successfully synthesized by employing enantiopure imidazolate derivatives. The results open a new blueprint on the synthetic design of homochiral ZIFs for future applications.

Carbamate compositions and methods fo rmodulating the activity of the CHK1 enzyme

-

Page/Page column 29, (2008/06/13)

Described herein are carbamate compounds. Such compounds are capable of modulating the activity of a checkpoint kinase, and described herein are methods for utilizing such modulation to treat cell proliferative disorders. Also described are pharmaceutical

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 659724-77-3